IN2014MN02116A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02116A IN2014MN02116A IN2116MUN2014A IN2014MN02116A IN 2014MN02116 A IN2014MN02116 A IN 2014MN02116A IN 2116MUN2014 A IN2116MUN2014 A IN 2116MUN2014A IN 2014MN02116 A IN2014MN02116 A IN 2014MN02116A
- Authority
- IN
- India
- Prior art keywords
- solid composition
- ethylbicyclo
- hept
- proving
- aminomethyl
- Prior art date
Links
- 239000008247 solid mixture Substances 0.000 abstract 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 abstract 1
- CVBYVUQVPQRITK-UHFFFAOYSA-N acetic acid;benzenesulfonic acid Chemical compound CC(O)=O.OS(=O)(=O)C1=CC=CC=C1 CVBYVUQVPQRITK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013079006 | 2013-04-04 | ||
| PCT/JP2014/059812 WO2014163132A1 (ja) | 2013-04-04 | 2014-04-03 | アミノカルボン酸の塩の固形組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02116A true IN2014MN02116A (zh) | 2015-09-04 |
Family
ID=51658423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2116MUN2014 IN2014MN02116A (zh) | 2013-04-04 | 2014-04-03 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9675570B2 (zh) |
| EP (1) | EP2826477B1 (zh) |
| JP (1) | JP5627062B1 (zh) |
| KR (1) | KR102142257B1 (zh) |
| CN (1) | CN104334169B (zh) |
| BR (1) | BR112014029538B1 (zh) |
| CA (1) | CA2870675C (zh) |
| ES (1) | ES2638420T3 (zh) |
| HK (1) | HK1204559A1 (zh) |
| IN (1) | IN2014MN02116A (zh) |
| TW (1) | TWI645863B (zh) |
| WO (1) | WO2014163132A1 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016148264A1 (ja) * | 2015-03-19 | 2016-09-22 | 第一三共株式会社 | 着色剤を含有する固形製剤 |
| WO2016148263A1 (ja) * | 2015-03-19 | 2016-09-22 | 第一三共株式会社 | 抗酸化剤を含有する固形製剤 |
| FR3075662B1 (fr) * | 2017-12-21 | 2022-06-24 | Ifp Energies Now | Procede de pretraitement pour ameliorer le remplissage d'une enceinte avec des particules solides |
| KR20210038414A (ko) | 2018-07-30 | 2021-04-07 | 다이이찌 산쿄 가부시키가이샤 | 안정화제를 함유하는 의약품의 고형 제제 |
| WO2021132072A1 (ja) | 2019-12-23 | 2021-07-01 | 第一三共株式会社 | 滑らかな表面を有するフィルムコーティング錠 |
| WO2022024979A1 (ja) * | 2020-07-27 | 2022-02-03 | 第一三共株式会社 | ミロガバリンベシル酸塩を含有する口腔内崩壊錠 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3928183A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Lactamfreie cyclische aminosaeuren |
| JPH11189547A (ja) * | 1997-12-26 | 1999-07-13 | Taisho Pharmaceut Co Ltd | 安定化されたニコランジル製剤及びその製造方法 |
| JP2001064177A (ja) * | 1999-08-16 | 2001-03-13 | Schering Ag | ベンズアミド誘導体を有効成分とする製剤 |
| WO2006056874A1 (en) | 2004-11-25 | 2006-06-01 | Pfizer Limited | Salt form |
| GB0425955D0 (en) * | 2004-11-25 | 2004-12-29 | Pfizer Ltd | Salt form |
| JP4691434B2 (ja) * | 2005-11-08 | 2011-06-01 | 東和薬品株式会社 | 安定化されたカベルゴリン固形製剤 |
| RU2446148C2 (ru) * | 2007-09-28 | 2012-03-27 | Дайити Санкио Компани, Лимитед | Бициклическое производное гамма-аминокислоты |
| CA2734847C (en) | 2008-08-18 | 2016-08-30 | Mitsubishi Shoji Foodtech Co., Ltd. | Novel excipient for mannitol tableting |
| JP2010241796A (ja) * | 2009-03-17 | 2010-10-28 | Daiichi Sankyo Co Ltd | 二環性γ−アミノ酸誘導体含有医薬組成物 |
| CA2756750C (en) * | 2009-03-26 | 2014-05-13 | Daiichi Sankyo Company, Limited | A method for producing bicyclic .gamma.-amino acid derivative |
| US9446055B2 (en) * | 2009-08-11 | 2016-09-20 | Fuji Chemical Industry Co., Ltd. | Disintegrating particle composition and orally rapidly disintegrating tablet |
-
2014
- 2014-04-03 TW TW103112494A patent/TWI645863B/zh active
- 2014-04-03 JP JP2014532752A patent/JP5627062B1/ja active Active
- 2014-04-03 IN IN2116MUN2014 patent/IN2014MN02116A/en unknown
- 2014-04-03 KR KR1020147032839A patent/KR102142257B1/ko active IP Right Grant
- 2014-04-03 EP EP14779687.4A patent/EP2826477B1/en active Active
- 2014-04-03 CA CA2870675A patent/CA2870675C/en active Active
- 2014-04-03 WO PCT/JP2014/059812 patent/WO2014163132A1/ja active Application Filing
- 2014-04-03 BR BR112014029538-7A patent/BR112014029538B1/pt active IP Right Grant
- 2014-04-03 CN CN201480001374.3A patent/CN104334169B/zh active Active
- 2014-04-03 ES ES14779687.4T patent/ES2638420T3/es active Active
- 2014-11-25 US US14/553,341 patent/US9675570B2/en active Active
-
2015
- 2015-05-28 HK HK15105091.0A patent/HK1204559A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1204559A1 (zh) | 2015-11-27 |
| EP2826477A4 (en) | 2015-09-09 |
| US9675570B2 (en) | 2017-06-13 |
| CN104334169A (zh) | 2015-02-04 |
| TW201517932A (zh) | 2015-05-16 |
| BR112014029538B1 (pt) | 2022-07-05 |
| ES2638420T3 (es) | 2017-10-20 |
| EP2826477B1 (en) | 2017-05-31 |
| JP5627062B1 (ja) | 2014-11-19 |
| KR102142257B1 (ko) | 2020-08-07 |
| TWI645863B (zh) | 2019-01-01 |
| EP2826477A1 (en) | 2015-01-21 |
| WO2014163132A1 (ja) | 2014-10-09 |
| CA2870675C (en) | 2017-03-28 |
| CN104334169B (zh) | 2016-11-02 |
| BR112014029538A2 (pt) | 2017-06-27 |
| JPWO2014163132A1 (ja) | 2017-02-16 |
| CA2870675A1 (en) | 2014-10-09 |
| KR20150138800A (ko) | 2015-12-10 |
| US20150079166A1 (en) | 2015-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02116A (zh) | ||
| EA201690598A1 (ru) | Аминогетероарил бензамиды в качестве ингибиторов киназы | |
| PH12018501099A1 (en) | Novel biphenyl compound or salt thereof | |
| PH12015501996B1 (en) | Heterocyclic compounds and uses thereof | |
| NZ714283A (en) | Novel histone deacetylase inhibitors | |
| JO3317B1 (ar) | مركبات تترا هيدروبيرولو ثيازين | |
| DK2840080T3 (da) | Nitrogenholdig heterocyklisk forbindelse eller salt deraf | |
| NZ716840A (en) | Combination formulation of two antiviral compounds | |
| GEP201706671B (en) | Heterocyclyl compounds as mek inhibitors | |
| MX2016006336A (es) | Compuestos pirazolopirimidina. | |
| MD20140072A2 (ro) | Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
| EA201690247A1 (ru) | Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения | |
| PH12015502802A1 (en) | Formulation comprising a hypolipidemic agent | |
| RS54526B1 (en) | USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS | |
| EA201692548A1 (ru) | Минеральные аминокислотные комплексы активных веществ | |
| PH12015501752B1 (en) | Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors | |
| EA201690911A1 (ru) | Соединения диметилбензойной кислоты | |
| EA201592268A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 | |
| CA2891755C (en) | Substituted pyrido-piperazinone derivatives as gamma secretase modulators | |
| MX364400B (es) | Compuestos de tetraciclina. | |
| WO2016068580A3 (en) | Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms) | |
| PH12016500577B1 (en) | Piperazine derivatives and the use thereof as medicament | |
| BR112017004166A2 (pt) | sal de derivado de cefalosporina, forma sólida cristalina do mesmo e método para produzir o mesmo | |
| EA201400473A1 (ru) | Способ синтеза 3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбонитрила и применение для синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
| GEP20186874B (en) | Hydrochloride salts of an antibiotic compound |